VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $317,000 | -60.3% | 3,125 | -30.2% | 0.02% | -61.9% |
| Q3 2015 | $799,000 | -27.9% | 4,480 | -10.2% | 0.06% | +1.6% |
| Q2 2015 | $1,108,000 | -10.6% | 4,989 | -20.0% | 0.06% | +12.7% |
| Q1 2015 | $1,239,000 | -5.0% | 6,236 | -31.5% | 0.06% | -6.8% |
| Q4 2014 | $1,304,000 | -13.6% | 9,107 | -20.8% | 0.06% | -11.9% |
| Q3 2014 | $1,509,000 | -41.8% | 11,504 | -44.1% | 0.07% | -40.7% |
| Q2 2014 | $2,594,000 | -2.3% | 20,570 | +2.1% | 0.11% | -6.6% |
| Q1 2014 | $2,656,000 | +11.2% | 20,148 | -0.9% | 0.12% | +16.3% |
| Q4 2013 | $2,388,000 | +13.8% | 20,340 | +1.1% | 0.10% | +4.0% |
| Q3 2013 | $2,099,000 | +38.3% | 20,121 | +14.1% | 0.10% | +29.9% |
| Q2 2013 | $1,518,000 | – | 17,634 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |